ACL
TMDX icon

APEIRON Capital Ltd’s Transmedics TMDX Stock Holding History

APEIRON Capital Ltd’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,500
Closed -$468K – 16
2024
Q4 		$468K Buy
+7,500
New +$698K 0.17% 13
2023
Q3 		– Sell
-11,554
Closed -$970K – 16
2023
Q2 		$970K Buy
+11,554
New +$884K 0.59% 14

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

APEIRON Capital Ltd's TMDX Position: Q1 2025 in Review

APEIRON Capital Ltd sold out of Transmedics (TMDX) in Q1 2025, closing a stake of 7,500 shares — an estimated $468K sold.

APEIRON Capital Ltd first reported a position in TMDX in Q2 2023 and held it in 2 quarters. The position peaked at $970K in Q2 2023. 299 funds tracked by Wall St. Rank hold TMDX as of Q1 2025.

  • APEIRON Capital Ltd reported no remaining Transmedics position as of Q1 2025 after selling out during the quarter.
  • APEIRON Capital Ltd sold 7,500 Transmedics shares in Q1 2025, an estimated $468K.
  • APEIRON Capital Ltd first reported a position in Transmedics in Q2 2023 and held it in 2 quarters.
  • APEIRON Capital Ltd's Transmedics position peaked at $970K in Q2 2023.
  • 299 funds tracked by Wall St. Rank held Transmedics as of Q1 2025.

Based on APEIRON Capital Ltd's 13F filing for Q1 2025, filed 23 Apr 2025.